Hypertonic saline nasal irrigation and gargling should be considered as a treatment option for COVID-19

Authors: Ramalingam, Sandeep;

Graham, Catriona;

Dove, Jenny;

Morrice, Lynn;

Sheikh, Aziz

Source: Journal of Global Health

Full text

: https://doi.org/10.7189/jogh.10.010332

Abstract

Post-hoc secondary analysis of data from our recent Edinburgh and Lothians Viral Intervention Study (ELVIS) pilot randomised controlled trial (RCT) indicates that hypertonic saline nasal irrigation and gargling (HSNIG) reduced the duration of coronavirus upper respiratory tract infection (URTI) by an average of two-and-a-half days. As such, it may offer a potentially safe, effective and scalable intervention in those with Coronavirus Disease-19 (COVID-19) following infection with the betacoronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Rights

This work is licensed under a Creative Commons Attribution 4.0 International License. https://creativecommons.org/licenses/by/4.0/

Cite as

Ramalingam, S., Graham, C., Dove, J., Morrice, L. & Sheikh, A. 2020, 'Hypertonic saline nasal irrigation and gargling should be considered as a treatment option for COVID-19', Journal of Global Health, 10(1), pp. 1-4. https://doi.org/10.7189/jogh.10.010332

Downloadable citations

HTML BIB RIS

Identifiers

DOI: https://doi.org/10.7189/jogh.10.010332

Repository URI: https://www.research.ed.ac.uk/portal/en/publications/hypertonic-saline-nasal-irrigation-and-gargling-should-be-considered-as-a-treatment-option-for-covid19(6d58bd7e-c6ff-418a-a4cb-82c7ea79fac3).html